Preliminary studies on human aldosterone synthase (CYP11B2) gene polymorphism,matrix metalloprotease-9,apoptosis,and carotid atherosclerosis plaque size by proton magnetic resonance imaging
Restricted accessOtherFirst published online September, 2010
Preliminary studies on human aldosterone synthase (CYP11B2) gene polymorphism,matrix metalloprotease-9,apoptosis,and carotid atherosclerosis plaque size by proton magnetic resonance imaging
Hypothesis. Aldosterone has direct or indirect effects on atherosclerosis, and polymorphisms occur in the gene encoding aldosterone synthase (CYP11B2), the enzyme catalysing aldosterone biosynthesis. Genetic variations in aldosterone synthesis may influence progression of carotid atherosclerosis.
Materials and methods. Ten subjects were genotyped through the use of the polymerase chain reaction for two diallelic polymorphisms in CYP11B2: one in the transcriptional regulatory region (promotor) and the other in the second intron. In vivo plaque size was estimated by H-1 magnetic resonance imaging using gradient echo pulse sequence. Media-intima thickness and ex vivo plaque in endarterectomy samples were measured by histology. Matrix metalloprotease (MMP)-9 was stained in endarterectomy histology sections and apoptosis index was counted in these sections.
Results. The CYP11B2 promoter genotype patterns were associated significantly with the plaque size in carotid artery (r2=0.9987; p=0.001), MMP-9 levels (r 2=0.9878; p=0.0001) and apoptotic indices (r2=0.9495; p=0.005) by multiple regression analysis. The media-intima thickness was not significantly correlated with genotype patterns.
Conclusion. Genetic variations in aldosterone synthase (CYP11B2) gene are associated with the progression of atherosclerotic plaque size, MMP-9 and apoptosis in the carotid artery.
Rossi G., Rossi A., Zanin L., Calabro A., Crepaldi G., Pessina ACPrevalence of extracranial carotid artery lesions at duplex in primary aldosteronism . Am J Hypertens1993;6(1):8-14.
2.
Paivansalo M. , Rantala A., Kauma H. et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens1996;14:1433-9.
3.
Kupari M., Hautanen A., Lankinen L. et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphism and left venricular size, mass, and function. Circulation1998;97:569-75.
4.
Dessi-Fulgheri P., Catalini R., Sarzani R. et al. Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens1995;13:1593-6.
5.
Choudhary S. , Higgins CL, Chen IY, Reardon M., Lawrie G. et al. Quantification and localization of metrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol. 2006 ; 26:2351-58.
6.
Brown DL, Hibbs MS, Kearney M., Lousin C., Isner JMIdentification of 92kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme with unstable angina. Circulation1995;91:2125-31.
7.
Odake S., Morita Y., Morikawa T., Yoshida N., Hori H., Nagai Y.Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids. Biochem Biophys Res Commun1994;199:1442-6.
8.
Yuan C., Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation2001;104:2051-6.
9.
Watanabe Y., Ishigami T., Kawano Y. et al. Angiotensin-converting enzyme gene I/D polymorphism and carotid plaques in Japanese. Hypertension1997;30:569-73.
10.
Jeng JRCarotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension. Am J Hypertens2000;13:111-19.
11.
Pujia A., Motti C., Irace C. et al. Deletion polymorphism in angiotensin converting enzyme gene associated with carotid wall thickening in a healthy male population. Coron Artery Dis1996;7(1):51-5.
12.
Kauma H., Paivansalo M., Savolainen MJ et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens1996 ;14:1183-7.
13.
Huang XH, Loimaala A., Nenonen A. et al. Relationship of angiotensin-converting enzyme gene polymorphism to carotid wall thickness in middle-aged men. J Mol Med1999;77:853-8.
14.
Hung J., McQuillan BM, Nidorf M., Thompson PL, Beilby JPAngiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb Vasc Biol1999;19:1969-74.
15.
Sharma R.Proton magnetic resonance microimaging as MRI marker in carotid artery atherosclerotic plaque: ex vivo MR microimaging analysis with histopathological correlation . Magn Reson Med Sci2002;1:217-33.
16.
Mannami T., Katsuya T., Baba S. et al. Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study. Stroke2001;32:1250-6.
17.
Pall D., Settakis G., Katona E. et al. Angiotensin-converting enzyme gene polymorphism, carotid intima-media thickness, and left ventricular mass index in adolescent hypertension. J Clin Ultrasound2004;32:129-35.
18.
Pall D., Settakis G., Katona E. et al.; Debrecen Hypertension Study. Increased common carotid artery intima media thickness in adolescent hypertension: results from the Debrecen Hypertension Study. Cerebrovasc Dis2003;15:167-72.
19.
Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JCAngiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis . Stroke2003;34:1634-9.
20.
Taute BM, Seifert H., Taute R., Glaser C., Podhaisky H.Angiotensin-converting enzyme gene insertion/deletion polymorphism and carotid artery wall thickness in patients with peripheral arterial occlusive disease . Int Angiol2000;19:337-44.
21.
Bednarska Makaruk MG, Rodo M., Markuszewski C. et al. Polymorphisms of apolipoprotein E and angiotensin-converting enzyme genes and carotid atherosclerosis in heavy drinkers . Alcohol Alcohol2005;40:274-82.
22.
Jeng JRLeft ventricular mass, carotid wall thickness, and angiotensinogen gene polymorphism in patients with hypertension. Am J Hypertens1999;12:443-50.
23.
Mattace-Raso FU, Van Der Cammen TJ, Sayed-Tabatabaei FA et al. Angiotensin-converting enzyme gene polymorphism and common carotid stiffness; The Rotterdam Study. Atherosclerosis2004;174:121-6.
24.
Connell JM, Fraser R., MacKenzie SM et al. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol2004;217:243-7.
25.
Nicod J., Bruhin D., Auer L., Vogt B., Frey FJ, Ferrari P.A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab2003;88:2495-500.
26.
Davies E., Holloway CD, Ingram MC et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 . Hypertension1999;33:703-07.
27.
Payne JR, Dhamrait SS, Toor IS et al. The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men. Atherosclerosis2004 ;174(1):81-6.
28.
Rodriguez M. , Lucchesi BR, Schaper J.Apoptosis in myocardial infarction. Ann Med2002;34:470-9.
